New insights into the causes and treatments of Alzheimer’s are offering hope for those at risk and those who are battling the ...

Anavex (AVXL) blarcamesine faces uncertain FDA path in early Alzheimer’s; Phase 3 may be needed. Read here a detailed ...

Following the hard-won success of early anti-amyloid drugs, a new generation of Alzheimer’s modalities—from tau-targeting ...

Scientists have found a possible explanation for why cancer patients are less likely to develop Alzheimer's. The enemy of our ...

The State House's Hall of Flags was covered in purple Thursday morning for Alzheimer's Advocacy Day.

An experimental treatment has revived cognition in a patient with advanced Alzheimer's. The finding has prompted a clinical ...

Topeka's Cotton O'Neil is using a new, early diagnosis tool to test new Alzheimer's treatments.

Conventional treatments of Alzheimer's disease, one of the most common forms of dementia, have been largely focused on ...

Alzheimer’s disease is a progressive neurodegenerative disease that affects an individual’s behavior, memory, and mental capabilities. Alzheimer’s allows for the build-up of proteins in the brain, ...

THC plus a common anti-inflammatory drug show promise.

“Pothead” could one day get a whole new meaning. A new study suggests low doses of THC, the main psychoactive ingredient in ...

In A Nutshell A mouse study found that low-dose THC combined with celecoxib protected memory and reduced brain damage linked to Alzheimer’s. THC alone reduced toxic proteins but also increased ...